RecruitingEarly Phase 1NCT05946785

Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes

Role of Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes

Sponsor

Anna Stanhewicz, PhD

Enrollment

28 participants

Start Date

Jul 1, 2023

Study Type

INTERVENTIONAL

Conditions

Gestational Diabetes Vascular Endothelial Function

Summary

The purpose of this investigation is to examine the role of oxidative stress in aberrant microvascular function in otherwise healthy women with a history of GDM.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Acetylcholine and a drug called insulin aspart for people with gestational diabetes and vascular endothelial function. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.